Asthma drug can block crucial SARS-CoV-2 protein
The Pharma Data
APRIL 26, 2022
A drug used to treat asthma and allergies can bind to and block a crucial protein produced by the virus SARS-CoV-2, and reduce viral replication in human immune cells, according to a new study by researchers at the Indian Institute of Science (IISc). Targeting Nsp1 could therefore reduce the damage inflicted by the virus.
Let's personalize your content